XML 90 R38.htm IDEA: XBRL DOCUMENT v2.4.0.6
Acquisitions (Narrative) (Details) (Neuro Nexus Technologies Inc [Member], USD $)
In Millions, unless otherwise specified
 0 Months Ended
Feb. 16, 2012
Neuro Nexus Technologies Inc [Member]
  
Business Acquisition [Line Items]  
Business Acquisition, Name of Acquired Entity NeuroNexus Technologies, Inc.
Business Acquisition, Description of Acquired Entity NeuroNexus is an active implantable medical device design firm specializing in developing and commercializing neural interface technology, components and systems for neuroscience and clinical markets. NeuroNexus has an extensive intellectual property portfolio, core technologies and capabilities to support the development and manufacturing of neural interface devices across a wide range of applications including neuromodulation, sensing, optical stimulation and targeted drug delivery. The aggregate purchase price of NeuroNexus was $13.2 million. Total assets acquired from NeuroNexus were $14.6 million, of which $2.9 million were amortizing intangible assets and $8.9 million was allocated to goodwill.
Business Acquisition, Cost of Acquired Entity, Cash Paid $ 11.7
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High 2
Business Acquisition, Contingent Consideration, at Fair Value $ 1.5
Business Acquisition, Purchase Price Allocation, Status The valuation of the assets acquired and liabilities assumed from NeuroNexus was finalized during the first quarter of 2013 and did not result in a material adjustment to the original valuation of net assets acquired, including goodwill.